Acura Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2013 | 123K | -13.90M | -11301.63% |
|---|---|---|---|
| 2014 | 751K | -13.20M | -1758.85% |
| 2015 | 8.58M | -4.98M | -58.1% |
| 2016 | 4.46M | -7.38M | -165.5% |
| 2017 | 2.96M | -5.68M | -191.57% |
| 2018 | 410K | -3.84M | -937.07% |
| 2019 | 2.65M | -3.95M | -148.66% |
| 2020 | 3.57M | -1.65M | -46.44% |
| 2021 | 1.56M | -1.07M | -69.03% |
| 2022 | 0 | 0 |
ACUR Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 1.56M | 3.57M | 2.65M | 410K | 2.96M | 4.46M | 8.58M | 751K | 123K |
Cost of revenue | 0 | 1.21M | 1.78K | 1.50K | 1.75K | 128K | 451K | 656K | 227K | 114K |
Gross profit | 0 | 352K | 3.56M | 2.65M | 408.24K | 2.83M | 4.01M | 7.93M | 524K | 9K |
Operating exp. | ||||||||||
Research and development | 0 | 1.52M | 1.78M | 1.50M | 1.75M | 3.72M | 4.02M | 2.60M | 4.58M | 4.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 2.56M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 2.77M | 4.32M | 3.38M | 4.32M | 8.06M | 10.57M | 11.93M | 12.72M | 13.84M |
Operating income | 0 | -1.21M | -758K | -725K | -3.91M | -5.22M | -6.55M | -4.00M | -12.19M | -14.09M |
Other income (expenses), net | 0 | 335K | -450K | -3.04M | 296K | -592K | 62K | -988K | -1.01M | -52K |
Income before tax | 0 | -879K | -1.20M | -3.77M | -3.84M | -5.81M | -7.38M | -4.98M | -13.20M | -13.90M |
Income tax expense | 0 | 200K | 450K | 176K | 468K | -135K | 550K | 828K | 938K | 9K |
Net income | 0 | -1.07M | -1.65M | -3.95M | -3.84M | -5.68M | -7.38M | -4.98M | -13.20M | -13.90M |
Earnings per share | ||||||||||
Basic EPS | 0 | -0.01 | -0.05 | -0.15 | -0.18 | -0.36 | -0.62 | -0.46 | -1.35 | -1.46 |
Diluted EPS | 0 | -0.01 | -0.05 | -0.15 | -0.18 | -0.36 | -0.62 | -0.46 | -1.35 | -1.46 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |